Skip to main content
OpenTrials
Completed

NCT Number: NCT06858085

The Turkish Version of the Late Life Function and Disability Instrument

The aim of this study is to investigate the Turkish validity and reliability of the Late Life Function and Disability Instrument (LLFDI) and to provide a measurement tool for researchers who wish to work in this field within the Turkish literature.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

65 year–105 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Istanbul Okan University

Istanbul, 34010, Turkey (Türkiye)

About this study

Short Physical Performance Battery (SPPB), Timed Up and Go Test (TUG), Functional Independence Measure (FIM), and Barthel Index of Activities of Daily Living (MBI), among others. However, these tests were designed without a clear theoretical or conceptual framework, and their utility and applicability are limited by the physical and cognitive condition of the individuals being assessed. There is a need for practical, adequate, tolerable, and reliable tests that provide consistent results and allow for a comprehensive evaluation of functional status and the effects of treatment.

Considering the existing tests, the Late Life Function and Disability Instrument (LLFDI) was developed by professors in the Department of Physical Therapy at Boston University to assess meaningful changes in both function and disability categories. The LLFDI has been translated into Hebrew, Swedish, French, Korean, Spanish, Canadian Portuguese, and Brazilian Portuguese, with its reliability and validity confirmed. This instrument is widely used in many countries worldwide.

However, there is currently no study on the Turkish version, validity, and reliability of the Late Life Function and Disability Instrument (LLFDI).

The aim of this study is to investigate the validity and reliability of the Turkish version of the Late Life Function and Disability Instrument (LLFDI) and to provide a measurement tool for researchers in this field to be used in the Turkish literature.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • over 65 years old,
  • being willing and volunteer to participate in the study,
  • having reading and writing skills,
  • being able to read and write in Turkish,
  • having a diagnosis of gonarthrosis, and
  • scoring above 20 points on the Mini-Mental Test.

Exclusion criteria

  • Having a neurological problem

Treatment and study plan

Turkish Version of the Late Life Function and Disability Instrument

Other

The Late Life Function and Disability Instrument (LLFDI) was developed to assess significant changes in functional and disability categories

Primary outcomes

  1. Patient Assessment Form

    Time frame: Baseline

    The form, prepared by the researcher, consists of 18 questions aimed at obtaining information on the sociodemographic characteristics of patients. Sociodemographic characteristics include address, age, gender, height, body weight, occupation, education level, social security status, marital status, and dominant hand.

    Additionally, fall history, medical history, family history, and use of assistive devices will be recorded to obtain general health information.

  2. Mini-Mental Test (MMT)

    Time frame: Baseline

    The Mini-Mental Test (MMT) is widely used in clinical practice for detecting cognitive impairments, monitoring the progression of dementia syndromes, and assessing responses to treatment. It is also used in epidemiological studies involving elderly individuals living in the community or in institutions.

    The test consists of 11 items grouped under five main sections:

    Orientation Registration memory Attention and calculation Recall Language The total score is 30 points, and it is one of the most commonly used tests for detecting dementia. It was first described by Folstein (1975) and later refined by Molloy et al. (1991). The test has been validated and found to be reliable in the Turkish population. However, since it was initially applicable only to educated elderly individuals, it was revised in 2008 by Keskinoglu et al. to ensure its validity and reliability for both educated and uneducated elderly populations.

  3. Late Life Function and Disability Instrument

    Time frame: Baseline

    The Late Life Function and Disability Instrument (LLFDI) was developed to assess significant changes in functional and disability categories.

    The function component consists of 32 questions and is evaluated in three domains:

    Upper extremity function (7 questions: F1, F3, F5, F6, F13, F16, F17) Basic lower extremity function (14 questions: F2, F10, F11, F12, F14, F15, F18, F21, F22, F23, F25, F26, F28, F31) Advanced lower extremity function (11 questions: F4, F7, F8, F9, F19, F20, F24, F27, F29, F30, F32) Each question is scored using a 5-point rating scale.

    The disability component consists of 16 questions, evaluated in two dimensions:

    Frequency Limitation Both dimensions use a 5-point rating scale. The total score of the scale is 100, with higher scores indicating better functional status.

    The scale was originally developed in the United States by Jette et al. in 2002

  4. Barthel Activities of Daily Living Index

    Time frame: Baseline

    The Barthel Index assesses an individual's ability to perform daily activities independently, such as:

    Eating Using the toilet Bathing Moving indoors and outdoors

    The total score is 100, and the dependency levels are classified as follows:

    0-20 points → Completely dependent 21-61 points → Severely dependent 62-90 points → Moderately dependent 91-99 points → Mildly dependent 100 points → Fully independent The Barthel Index (BI) was developed by Mahoney and Barthel in 1965. The validity and reliability of its Turkish version were studied by Küçükdeveci et al. in 2000

  5. Functional Independence Measure

    Time frame: Baseline

    The Functional Independence Measure (FIM) evaluates an individual's ability to perform daily activities independently in two domains:

    Motor Cognitive

    The total score is 126, and each item is rated as follows:

    7 points → Fully independent 6 points → Modified independence 5 points → No physical assistance needed, only verbal cues 4 points → Minimal assistance (the patient performs at least 75% of the effort) 3 points → Moderate assistance (50-75% effort by the patient) 2 points → Maximum assistance (25-50% effort by the patient)

    1 point → Total assistance The scale was first developed by Karyl et al. in 1993

  6. Lequesne Algofunctional Knee Index

    Time frame: Baseline

    The Lequesne Algofunctional Knee Index is designed to evaluate patients with gonarthrosis and consists of three main components:

    Pain or discomfort Maximum walking distance Activities of daily living

    The total score is 24:

    For the first and second sections, scores range from 0 (no pain or functional limitation) to 8 (severe pain or functional limitation).

    The maximum walking distance section is scored from 0 (no limitation) to 6 (walking less than 100 m).

    If the patient uses one cane or crutch, 1 point is added; if they use two canes or crutches, 2 points are added.

    Higher scores indicate worse health status. This index was developed by Lequesne et al. in 1987

Sponsors and collaborators

Lead sponsor

Okan University

Other

Registry information

Official study title

The Turkish Version of the Late Life Function and Disability Instrument in Geriatric Individuals With Gonarthrosis: A Validity and Reliability Study

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Mar 5, 2025
Registry last updated
Apr 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.